Indefinite Delivery Contract SPE2DU25D5339

The federal contract IDV award was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to establish a Pharmaceutical Prime Vendor Global Program Generation V contract. This single-award indefinite delivery contract, valued at $999,999,999, has a period of performance from November 2025 through December 2026, with the potential for three 30-month option periods.

The purpose of this contract is to provide worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as related medical supplies and equipment, to the Department of Defense, United States Coast Guard, and other designated government customers and medical facilities. The contracted products and services are intended to support normal day-to-day operations, as well as planned and unplanned contingencies, Prime Vendor Readiness, and War Readiness Materiel requirements for both CONUS and OCONUS locations. The contract is a firm-fixed-price, requirements-type contract with a lowest price technically acceptable evaluation criteria, and the potential use of reverse auctions to determine the final distribution fees.